Literature DB >> 11448157

Analysis of dominant-negative effects of mutant Env proteins of human immunodeficiency virus type 1.

Y Iwatani1, K Kawano, T Ueno, M Tanaka, A Ishimoto, M Ito, H Sakai.   

Abstract

The Env protein of human immunodeficiency virus type 1 is assembled into a stable trimer, and oligomerization is required for maintenance of viral infectivity. This property of Env suggests that Env mutants may have a dominant-negative effect on virus infectivity. To investigate this possibility, we established a packaging cell line in which both wild-type and mutant Env proteins could be expressed simultaneously in a single cell. We analyzed the effects of two types of Env mutants: cytoplasmic tail-truncated TM mutants and a mutant defective in gp120/gp41 cleavage. The cytoplasmic tail-truncated proteins were found to be incorporated into virions by forming an oligomer with wild-type TM, but could not inhibit the wild-type function. In contrast, phenotypic mixing of cleavage-defective Env with the wild-type protein caused dramatic inhibition of infectivity, indicating that this mutant has a strong dominant-negative phenotype. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11448157     DOI: 10.1006/viro.2001.0944

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  14 in total

1.  Identification of the LWYIK motif located in the human immunodeficiency virus type 1 transmembrane gp41 protein as a distinct determinant for viral infection.

Authors:  Steve S-L Chen; Polung Yang; Po-Yuan Ke; Hsiao-Fen Li; Woan-Eng Chan; Ding-Kwo Chang; Chin-Kai Chuang; Yu Tsai; Shu-Chen Huang
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

2.  Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies.

Authors:  Pascal Poignard; Maxime Moulard; Edwin Golez; Veronique Vivona; Michael Franti; Sara Venturini; Meng Wang; Paul W H I Parren; Dennis R Burton
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Wild-type-like viral replication potential of human immunodeficiency virus type 1 envelope mutants lacking palmitoylation signals.

Authors:  Woan-Eng Chan; Hui-Hua Lin; Steve S-L Chen
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Assembly and characterization of gp160-nanodiscs: A new platform for biochemical characterization of HIV envelope spikes.

Authors:  Eri Nakatani-Webster; Shiu-Lok Hu; William M Atkins; Carlos Enrique Catalano
Journal:  J Virol Methods       Date:  2015-09-28       Impact factor: 2.014

5.  Stoichiometry of antibody neutralization of human immunodeficiency virus type 1.

Authors:  Xinzhen Yang; Svetla Kurteva; Sandra Lee; Joseph Sodroski
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

6.  Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins.

Authors:  James M Binley; Rogier W Sanders; Aditi Master; Charmagne S Cayanan; Cheryl L Wiley; Linnea Schiffner; Bruce Travis; Shawn Kuhmann; Dennis R Burton; Shiu-Lok Hu; William C Olson; John P Moore
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

7.  In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1.

Authors:  Daniel P Leaman; Heather Kinkead; Michael B Zwick
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

8.  Modeling how many envelope glycoprotein trimers per virion participate in human immunodeficiency virus infectivity and its neutralization by antibody.

Authors:  Per Johan Klasse
Journal:  Virology       Date:  2007-09-07       Impact factor: 3.616

9.  Mutations in envelope gp120 can impact proteolytic processing of the gp160 precursor and thereby affect neutralization sensitivity of human immunodeficiency virus type 1 pseudoviruses.

Authors:  Wendy M Blay; Theresa Kasprzyk; Lynda Misher; Barbra A Richardson; Nancy L Haigwood
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

10.  Complementation of diverse HIV-1 Env defects through cooperative subunit interactions: a general property of the functional trimer.

Authors:  Karl Salzwedel; Edward A Berger
Journal:  Retrovirology       Date:  2009-08-11       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.